Dr Sanae Reggoug Gastroenterologist & Hepatologist

Board certified gastroenterologist and hepatologist, with 15 years post graduation experience. Advanced skills in diagnostic and therapeutic upper and lower digestive endoscopy, abdominal ultrasonography and functional digestive explorations, with great ability to provide comprehensive gastrointestinal work up to my patients.

More than 10 years of practice in Dubai, with acquisition of great local experience and establishment of wide multicultural patients’ base and referrals network.

My evidence-based medicine practice, commitment to high quality patients’ care, multilingualism and teamwork skills position me as a valuable asset.

• Literature, Trekking, Gastronomy, Gardening

1. Digestive angiodysplasia revealing an acquired von Willebrand syndrome associated to a multiple myeloma. Acta Endoscopica 2007 ; 37 (4): 1-11 (SMIER award 2008)

2. Review : Medical treatment of hydatic cyst. Le Repère Médical 2008; 21(1370): 2-5

3. Celiac disease and sarcoidosis. GastroenterolClinBiol 2009 ; 33(5): 430-432

4. Idiopathic gastric acid hypersecretion in a patient with MUTYH-associated polyposis. American Journal of Gastroenterology 2009; 104(10):2648-9

5. Hyperplastic gastric polyposis and coeliac disease: an unusual association. Acta Endoscopica 2009; 39 (5) :348-352

6. Primary retroperitoneal mucinous cystadenocarcinoma in a male patient. Report of a case. Cases Journal 2009, 2:7196

7. Celiac disease complicated by a squamous cell carcinoma of the esophagus. Gastroenterol ClinBiol 2010;34(1):83-4.

8. Nutcracker esophagus: an acid related disease or a primary motor disorder?. Gastroenterol ClinBiol 2010;34(6-7):422-4.

9. Heterotopic pancreas: an unusual cause of epigastric pain. Gastroenterol Clin Biol. 2010 Dec;34(12):726-7

10. Management of dysphagia with normal endoscopic appearance (Review). Revue Marocaine des Maladies de l’Appareil Digestif, Oct 2010, vol. 8, p: 33-37.

11. Histological, molecular and immunohistologic Phenotype of IBD Related Colorectal Cancer.Gastroenterology, May 2011, 140(5), Supplement 1, p:S-429.

12. Non-association of Crohn's disease with NOD2 gene variants in Moroccan patients. Gene, May 2012, 499(1), p:121-3.

- 2010-2011 :

o Prevalence of NOD2 mutation and variants among Moroccan patients with Crohn’s disease (results published in the journal Genes - 2011)

o Gastroenterology Unit « B », University Hospital Ibn Sina, Rabat (Morocco).

o Genetic department, National Hygiene Institute, Rabat (Morocco).

- 2009-2010 :

o Epidemiological study of upper GI bleeding in Francophone Africa.

o Moroccan Association for Digestive Tract Diseases (SMMAD) and Francophone African Association of continuous medical education in gastroenterology and hepatology (AAFFCHGE).

- 2008-2009 :

o Molecular and immunohistological phenotypes of colorectal cancer associated with Inflammatory Bowel Disease.

o Results presented as a thesis, during DES courses in Angers (France).

- 2008-2009:

o Initiation of regional investigation in collaboration with general practitioners of Ille et Vilaine department (France) and ADECI35 (association for CRC screening in Ille et Vilaine)

o Causes of colonoscopy refusal and outcome of patients with positive Hemoccult® test, during the first campaign of CRC screening in Ille et Vilaine.

- 2006-2007:

o Elaboration of the first department digestive oncology register with a retrospective study of all cases registered during a decade (1996-2006)

o Gastroenterology Unit “B”, University Hospital Ibn Sina, Rabat, Morocco.

• September 2024 (Dubai, UAE)

o Speaker at the first CRC screening & Advanced Colonoscopy Techniques

o Oral Presentation : Bowel preparation, how to get it right!

• October 2021 (Dubai, UAE)

o Speaker, CME lecture under Dr Sulaiman Al Habib Medical group

o Oral presentation: IBS, translating new guidelines into practice

• March 2021 (Dubai, UAE)

o Speaker: How to prevent and identify colorectal cancer (AXA Gulf Group)

• December 2017 (Crown Plaza, Dubai, UAE)

o Speaker: Long term use of PPI, what should we tell our patients?

• October 2011 (Stockholm, Sweden)

o 19th United European Gastroenterology Week.

o Poster 0898: molecular and immunohistological phenotypes of colorectal cancer associated with inflammatory bowel disease: ck7+/ck20+ immunostaining is associated with advanced tumors.

• Novembre 2010 (Casablanca, Morocco) :

o Speaker: Abdominal ultrasonography in inflammatory bowel diseases.

o First edition in IBD courses.

• October 2010 (Barcelone, Spain)

o United European Gastroenterology Weak (UEGW).

o Poster: Managing the side effects of antiviral therapy for chronic hepatitis C: Moroccan monocentric experience of 138 patients.

• October 2010 (Casablanca, Morocco)

o Speaker: Clinical features of Crohn’s disease associated to NOD2 mutations among Moroccan patients.

o Annual national congress of the Moroccan Society for digestive tract diseases (SMMAD).